Abby Goodnough

Join science writer Carl Zimmer and health correspondent Abby Goodnough as they delve into the troubling emergence of a highly transmissible coronavirus variant from the UK. They discuss the latest updates on vaccine efficacy, particularly regarding Pfizer's effectiveness against mutations. The duo also examines the sluggish vaccine rollout in the U.S., highlighting challenges like staffing shortages and varying state responses, while shedding light on the urgent need for swift vaccination to combat the pandemic's evolving landscape.